How Does Vagus Nerve Stimulation Affect Blood Glucose, Food, and Movement Cravings?

ConditionVagus Nerve Stimulation

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-35

SponsorUniversity of Minnesota

About this trial

The purpose of this study is to determine the feasibility of using non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) to examine physiological and psychological responses in a college-aged healthy population

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Participants must be between the ages of 18 and 35 as we are focused on recruiting undergraduate and graduate students.

Disqualifiers

Participants will be excluded if they have epilepsy, clinically significant tachycardia or arrhythmia, diabetes (Type 1 or Type 2) or another metabolic disease, current pregnancy, any implanted electronic medical device (for example, pacemaker or defibrillator), or a known skin allergy to adhesives that would prevent CGM placement. Participants will also be excluded if they have a history of major depressive disorder if taVNS could reasonably be expected to alter mood symptoms

Trial design

Design model

Crossover

Treatments tested in this trial

Active taVNS
Device
Actual taVNS
Sham taVNS
Device
No nerve stimulation

Treatment groups

8 Participants

are divided into 2 treatment groups

Group A: Active taVNSActive comparator 1 intervention

Group B: Sham taVNSPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

Change in plasma glucose

Time frame

Hour 2 after oral glucose load

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Minnesota

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: